• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

Bicara Therapeutics aims for up to $828 mln valuation in U.S. IPO

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 06, 2024 at 11:12: AM
via Bicara Therapeutics said on Friday it is seeking a valuation of up to $828 million in its initial public offering in the United States, as new listings continue to flock the markets.

article source
 






Top Bottom
Back
Quote